- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
Even though the most recent guidance by the International Society for the Study of Hypertension in Pregnancy (ISSHP) has highlighted the role of angiogenic markers in the diagnosis of preeclampsia in women with chronic hypertension, it has withheld recommending its implementation due to the limited available evidence in this group of women. Therefore, we aimed to evaluate sFlt-1 (soluble fms like kinase 1) and PlGF (placental growth factor) in women with suspected superimposed preeclampsia.